Dr. Graff on the KEYNOTE-199 trial design in castration-resistant prostate cancer
February 19, 2020
At the 2020 American Society of Clinical Oncology Genitourinary Cancers Symposium, Julie Graff, M.D., presents phase 2 clinical trial results regarding treatment for a form of metastatic prostate cancer.